HomeEXAS • NASDAQ
add
Exact Sciences Corp
Nakaraang pagsara
$56.68
Sakop ng araw
$54.93 - $56.63
Sakop ng taon
$40.62 - $79.47
Market cap
10.46B USD
Average na Volume
1.95M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 708.66M | 12.78% |
Gastos sa pagpapatakbo | 531.08M | -0.43% |
Net na kita | -38.24M | -4,915.62% |
Net profit margin | -5.40 | -4,253.85% |
Kita sa bawat share | -0.13 | 59.97% |
EBITDA | 36.28M | 270.41% |
Aktuwal na % ng binabayarang buwis | -2.16% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.02B | 39.04% |
Kabuuang asset | 6.75B | 5.10% |
Kabuuang sagutin | 3.54B | 7.23% |
Kabuuang equity | 3.21B | — |
Natitirang share | 185.08M | — |
Presyo para makapag-book | 3.27 | — |
Return on assets | -0.69% | — |
Return on capital | -0.77% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -38.24M | -4,915.62% |
Cash mula sa mga operasyon | 138.72M | 469.43% |
Cash mula sa pag-invest | -81.72M | -147.86% |
Cash mula sa financing | -226.00K | -345.65% |
Net change in cash | 58.65M | 701.48% |
Malayang cash flow | 107.80M | 982.44% |
Tungkol
Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer. Wikipedia
CEO
Itinatag
Ene 1, 1995
Headquarters
Website
Mga Empleyado
6,550
